European Post-Authorization Registry for RAVICTI® (glycerol phenylbutyrate) Oral Liquid in Partnership with the European Registry and Network for Intoxication Type Metabolic Diseases (E-IMD) (HZNP-RAV-401)

16/01/2017
02/07/2024
EU PAS number:
EUPAS17267
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

V3 0_RAVICTI-EU-Registry_protocol__20161129_final-clean_incl app with redaction_Redacted_sk_Redacted_sk

English (2.7 MB - PDF) View document
Updated protocol

V5 0_RAVICTI-EU-Registry_protocol__26 Apr 2018_Final Signed_Complete_Redacted (2)

First published: 22/02/2024
English (9.18 MB - PDF) View document
Study results
Study results

HZNP-RAV-401_Synopsis

English (256.93 KB - PDF) View document
Study report
Other information